BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 27774765)

  • 1. Progress in the clinical detection of heterogeneity in breast cancer.
    Song JL; Chen C; Yuan JP; Sun SR
    Cancer Med; 2016 Dec; 5(12):3475-3488. PubMed ID: 27774765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumor Heterogeneity in Breast Cancer.
    Beca F; Polyak K
    Adv Exp Med Biol; 2016; 882():169-89. PubMed ID: 26987535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis.
    Chowdhury R; Ganeshan B; Irshad S; Lawler K; Eisenblätter M; Milewicz H; Rodriguez-Justo M; Miles K; Ellis P; Groves A; Punwani S; Ng T
    Br J Radiol; 2014 Jun; 87(1038):20140065. PubMed ID: 24597512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumor and circulating clonal heterogeneity shape the basis of precision breast cancer therapy.
    Ziogas DE; Spiliotis J; Lykoudis EG; Zografos GC; Roukos DH
    Future Oncol; 2017 Jan; 13(2):113-116. PubMed ID: 27581662
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular heterogeneity in breast cancer: State of the science and implications for patient care.
    Ellsworth RE; Blackburn HL; Shriver CD; Soon-Shiong P; Ellsworth DL
    Semin Cell Dev Biol; 2017 Apr; 64():65-72. PubMed ID: 27569190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells in breast cancer: functional heterogeneity, pathogenetic and clinical aspects.
    Cherdyntseva NV; Litviakov NV; Denisov EV; Gervas PA; Cherdyntsev ES
    Exp Oncol; 2017 Mar; 39(1):2-11. PubMed ID: 28361862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From K-space to Nucleotide: Insights Into the Radiogenomics of Brain Tumors.
    Elshafeey N; Hassan I; Zinn PO; Colen RR
    Top Magn Reson Imaging; 2017 Feb; 26(1):33-41. PubMed ID: 28079715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer intratumor genetic heterogeneity: causes and implications.
    Ng CK; Pemberton HN; Reis-Filho JS
    Expert Rev Anticancer Ther; 2012 Aug; 12(8):1021-32. PubMed ID: 23030222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of breast cancer: etiology and clinical relevance.
    Almendro V; Fuster G
    Clin Transl Oncol; 2011 Nov; 13(11):767-73. PubMed ID: 22082639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and Treatment of Breast Cancer in the Precision Medicine Era.
    Yan J; Liu Z; Du S; Li J; Ma L; Li L
    Methods Mol Biol; 2020; 2204():53-61. PubMed ID: 32710314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumoral heterogeneity of breast cancer.
    Roulot A; Héquet D; Guinebretière JM; Vincent-Salomon A; Lerebours F; Dubot C; Rouzier R
    Ann Biol Clin (Paris); 2016 Dec; 74(6):653-660. PubMed ID: 27848916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Genomic Testing for Breast Cancer: Utility for Surgeons.
    Fayanju OM; Park KU; Lucci A
    Ann Surg Oncol; 2018 Feb; 25(2):512-519. PubMed ID: 29159748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-to-mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity.
    Hong D; Fritz AJ; Zaidi SK; van Wijnen AJ; Nickerson JA; Imbalzano AN; Lian JB; Stein JL; Stein GS
    J Cell Physiol; 2018 Dec; 233(12):9136-9144. PubMed ID: 29968906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Classification of Breast Cancer.
    Provenzano E; Ulaner GA; Chin SF
    PET Clin; 2018 Jul; 13(3):325-338. PubMed ID: 30100073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay Between Genetic and Epigenetic Changes in Breast Cancer Subtypes.
    Dumitrescu RG
    Methods Mol Biol; 2018; 1856():19-34. PubMed ID: 30178244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumor genetic heterogeneity of breast carcinomas as determined by fine needle aspiration and TaqMan low density array.
    Lyng MB; Laenkholm AV; Pallisgaard N; Vach W; Knoop A; Bak M; Ditzel HJ
    Cell Oncol; 2007; 29(5):361-72. PubMed ID: 17726259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating breast cancer genetics into clinical practice.
    Mukherjee A; Rakha EA
    Womens Health (Lond); 2012 Jan; 8(1):99-112. PubMed ID: 22171779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
    Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
    Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
    [No Abstract]   [Full Text] [Related]  

  • 19. Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy.
    Koren S; Bentires-Alj M
    Mol Cell; 2015 Nov; 60(4):537-46. PubMed ID: 26590713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of breast cancer: The importance of interaction between different tumor cell populations.
    Januškevičienė I; Petrikaitė V
    Life Sci; 2019 Dec; 239():117009. PubMed ID: 31669239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.